Showing results (741-750 of 803) with videos related to

Sort By:
Pageof 81
The Journal of Clinical Endocrinology and Metabolism|December 1, 1981
Genetic and hormonal characterization of cryptic 21-hydroxylase deficiencyL S Levine, B Dupont, F Lorenzen, et al.
The Journal of Infectious Diseases|April 6, 2012
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needsAlimuddin Zumla, Ibrahim Abubakar, Mario Raviglione, et al.
The Lancet. Infectious Diseases|June 16, 2024
Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Jay Achar, Elmira Gurbanova, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 9, 2023
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network studyJoanitah Nalunjogi, Sergio Mucching-Toscano, Jean Pierre Sibomana, et al.
The European Respiratory Journal|April 13, 2012
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisGiovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, et al.
The European Respiratory Journal|May 2, 2009
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementU Mack, G B Migliori, M Sester, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2020
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis NetworkGiovanni Battista Migliori, Simon Tiberi, Alimuddin Zumla, et al.
Pulmonology|September 7, 2023
Vaccination in post-tuberculosis lung disease management: A review of the evidenceM J Nasiri, D R Silva, F Rommasi, et al.
The European Respiratory Journal|June 10, 2010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statementI Solovic, M Sester, J J Gomez-Reino, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 2, 2020
Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countriesSeif Al Abri, Thereza Kasaeva, Giovanni Battista Migliori, et al.
Pageof 81